Warren L. DeSouza is the Chief Financial Officer at Sila. Prior to Sila, Warren served as the Chief Financial Officer of Aimmune Therapeutics, Inc (NASDAQ:AIMT) and was responsible for Aimmune’s initial public offering. Prior to Aimmune, Warren served as Vice President of Finance for Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX). In this role, Warren was responsible for all accounting, SEC reporting, purchasing, tax and treasury functions of the company prior to its $10 billion acquisition by Amgen. Prior to that for 15 years, Warren was employed as a senior manager at the accounting firms of Deloitte & Touche, LLP and Arthur Andersen LLP, respectively.

Warren received a BBA from the University of Notre Dame and is a certified public accountant (inactive).